El Salvador vs Iran: Expected chances of death from non-communicable diseases, by gender
El Salvador
15.2%
in 2021
Iran
15.0%
in 2021
El Salvador rank
134th
Iran rank
136th
Expected chances of death from non-communicable diseases, by gender over time
- El Salvador
- Iran
How they compare
El Salvador currently reports 15.2% against 15.0% in Iran, a difference of 0.2%.
The two have swapped places 1 time across 22 shared years of data; in 2000 it was Iran ahead.
El Salvador ranks 134th and Iran ranks 136th of 185 countries.
Across the 3 decades both report, El Salvador averaged higher in 1 and Iran in 2.
Head to head by decade
| Decade | El Salvador | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 14.1% | 20.7% | 6.6% | Iran |
| 2010s | 14.9% | 18.0% | 3.0% | Iran |
| 2020s | 15.8% | 15.7% | 0.1% | El Salvador |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher expected chances of death from non-communicable diseases, by gender, El Salvador or Iran?
- El Salvador, at 15.2% against 15.0% in Iran as of 2021.
- What is the difference in expected chances of death from non-communicable diseases, by gender between El Salvador and Iran?
- 0.2%, with El Salvador ahead.
- How many years of comparable data are there for El Salvador and Iran?
- 22 years are reported by both, from 2000 to 2021.
- How do El Salvador and Iran rank globally for expected chances of death from non-communicable diseases, by gender?
- El Salvador ranks 134th and Iran ranks 136th of 185 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Expected chances of death from non-communicable diseases, by gender. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated share of 30-year-olds who would die before their 70th birthday from common non-communicable diseases: any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease.